Last week, www.selectscience.net reported
on 19 news stories the day they happened,
so if you need to keep up to speed on
the latest business developments in
chemistry and life science, make the news
ticker on www.selectscience.net part of
your daily routine.
Andrew Smith (andrew at selectscience.net)
Editor, www.selectscience.net
Last week's headlines were:
Genset and Janssen identify a novel candidate gene associated with
schizophrenia
Nova Molecular Inc. appoint Margaret Bywater as President, CEO & CSO
Gemini appoints Dr Roberto Rosenkranz as a non-executive director
DuPont Plans to Acquire CombiChem To Assist in Drug Discovery
Incyte and Millennium Enter Into Genomic Database and Bioinformatics
Partnership
Lexicon Genetics Announces Database Agreement With Millennium
Pharmaceuticals
ChemBridge Corporation Enters Combinatorial Chemistry Agreement with Roche
How State and Local Government Can Grow the Life Sciences Industry
Genentech Chairman/CEO Arthur Levinson receives Irvington Institute's
Corporate Leadership
Alpharma appoints Ms. Nancy V. Ryan Vice President of Human Resources
Merck Pharma Division establishes strong presence in United States, names
new global Management Board
Genentech appoints Daniel S. Sulzbach to Vice President, Information
Resources
Genzyme Molecular Oncology Licenses Antisense Cancer Rights to Hybridon
Isis and Rhone-Poulenc Rorer Establish Antisense Target Validation
Collaboration
Abbott Laboratories in Discussion with the Food and Drug Administration
Regarding Compliance Issues in Diagnostics Division
Revised UK BioIndustry Association Code of Best Practice
Scientists unveil plastic plants
Dupont Pharmaceuticals, Janssen Pharmaceutica and Neurocrine Biosciences
enter into CRF agreement
Trega Biosciences announces management addition and new business
developments
